Alzheimer's Disease

Alzheimer's Disease

Image: Institute for Bioengineering of Catalonia (IBEC)

Breakthrough nanotechnology could help reverse Alzheimer’s damage

Instead of targeting neurons, the treatment repairs the blood–brain barrier (BBB) - a protective layer that keeps harmful substances out of the brain

Illustration: TBS

Revolution or mirage? Controversy surrounds new Alzheimer's drugs

In this undated photo provided by Massachusetts General Hospital, Dr. Francisco Lopera, left, of the University of Antioquia, a neurologist who has spent decades caring for a large Colombian family plagued by early-in-life Alzheimer’s, confers with fellow researcher Yakeel Quiroz of Massachusetts General Hospital. Photo: AP

Delaying Alzheimer’s onset: Colombian family’s genes offer new clue

The Alzheimer's drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Photo: Eisai/Handout via REUTERS/File Photo

Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA

Photo: UNB

After US approval, Japan okays its first Alzheimer's drug

Photo: Courtesy

World Alzheimer's Day observed by National Institute of Neurosciences and Incepta Pharmaceuticals

Dr. Seth Gale points out evidence of Alzheimer’s disease on an MRI at the Center for Alzheimer Research and Treatment (CART) at Brigham And Women’s Hospital in Boston, Massachusetts, U.S., March 30, 2023. REUTERS/Brian Snyder/File photo

Experimental drug works best for Alzheimer's patients treated as early as possible

Photo: MIT News Office

MIT scientists find way to reverse Alzheimer's symptoms

Illustration: TBS

Australian scientists make breakthrough in Alzheimer's research

Alzheimer's-slowing drug 'lecanemab' labelled historic

Alzheimer's-slowing drug 'lecanemab' labelled historic

A scan of a brain of a patient affected by Alzheimer's Disease. Source: BSIP/Universal Images Group via Getty Images

How a Japanese drugmaker got the ‘clean win’ over Alzheimer’s

Study finds the likely cause of Alzheimer's disease

Study finds the likely cause of Alzheimer's disease

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. Photo: AP via UNB

FDA approves much-debated Alzheimer’s drug panned by experts